September 15, 2022, Oslo
After having acted as Chairman of the Board of Directors in Carasent for
approximately 15 years, Johan Lindqvist announces that he will step down from
the position. Lindqvist will continue as Chairman until the next extraordinary
general meeting of Carasent, where a successor will be appointed. The company's
Nomination Committee has initiated the search process for a new Chairman.
Lindqvist and the Board depart on friendly terms and Lindqvist will continue to
assist the company to the best of his ability until a new Chairman is in effect.
"The company is entering into a new phase, and after 15 years it is time for me
to move on to other projects. I have experienced a fantastic journey with
Carasent, and my strong belief in a positive future for Carasent persists."
Johan Lindqvist remains a major shareholder of Carasent. Lindqvist and companies
controlled by him hold 2,044,337 shares and 78,573 subscription rights, in
Carasent. This equals a 2.6% ownership stake.
For further information, please contact Johan Lindqvist, Chairman of the Board
at +46 73355 0935 or Staffan Hanstorp, Vice-Chairman at +46 73377 2430.
About the company: Carasent ASA was founded in 1997. In May 2018, the Swedish
company Evimeria EMR AB, a company providing cloud-based medical record services
to the health care industry, was acquired. In December 2020 Carasent ASA
acquired the Norwegian company Avans Soma AS, a developer of leading medical
record systems and IT solutions in the Norwegian health care market. Metodika
AB, provider of Metodika EPM, a highly competitive all in one solution for
medium sized private clinics and hospitals in Europe, was acquired in May 2021.
Carasent's strategy is to develop and expand digitalization that helps customers
in providing efficient and qualitative health care services in the Scandinavian
market.
